Holsti M A, Allen P M
Center for Immunology and Department of Pathology, Washington University Medical Center, St. Louis, Missouri 63110, USA.
Infect Immun. 1996 Oct;64(10):4091-8. doi: 10.1128/iai.64.10.4091-4098.1996.
We have generated a murine T-cell hybridoma, 1C9, which recognizes an antigen expressed by a virulent clinical isolate of Mycobacterium avium. Both peritoneal exudate macrophages and bone marrow-derived macrophages infected in vitro with M. avium process and present the antigen to the T-cell hybridoma. Gel filtration chromatography of a sonicate of M. avium followed by T-cell Western blotting (immunoblotting) demonstrated that the antigen recognized by hybridoma 1C9 is approximately 50 kDa. In addition, treatment of macrophages with the lysosomotropic agent chloroquine or with inhibitors of acid proteases inhibits processing and presentation of the antigen. These results indicate that the antigen must encounter an acidic compartment with active proteases for processing and presentation to occur. Our results are discussed in the context of our current understanding of how mycobacterial antigens are processed and presented by infected macrophages to T cells.
我们制备了一种小鼠T细胞杂交瘤1C9,它能识别由鸟分枝杆菌的一种强毒临床分离株表达的抗原。用鸟分枝杆菌体外感染的腹膜渗出巨噬细胞和骨髓来源的巨噬细胞都能处理该抗原并将其呈递给T细胞杂交瘤。对鸟分枝杆菌超声裂解物进行凝胶过滤层析,随后进行T细胞免疫印迹分析(免疫印迹法),结果表明杂交瘤1C9识别的抗原约为50 kDa。此外,用溶酶体促渗剂氯喹或酸性蛋白酶抑制剂处理巨噬细胞会抑制该抗原的处理和呈递。这些结果表明,该抗原必须进入含有活性蛋白酶的酸性区室才能进行处理和呈递。我们将结合目前对感染巨噬细胞如何处理分枝杆菌抗原并将其呈递给T细胞的理解来讨论我们的结果。